Claim Missing Document
Check
Articles

Found 12 Documents
Search
Journal : JIFI (Jurnal Ilmiah Farmasi Imelda)

COST MINIMALIZATION ANALYSIS (CMA) PENGGUNAAN OBAT ANTIHIPERTENSI GOLONGAN CALCIUM CHANNEL BLOCKER KOMBINASI ANGIOTENSIN RECEPTOR BLOCKER PADA PASIEN HIPERTENSI DI RSU IMELDA PEKERJA INDONESIA MEDAN Gultom, Roby; Silvia, Mariani
JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 5 No. 2 (2022): JIFI (Jurnal Ilmiah Farmasi Imelda)
Publisher : Universitas Imelda Medan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52943/jifarmasi.v5i2.771

Abstract

Hypertension is a degenerative diseases that can take long treatments or even a lifetime. Hypertensive treatment costs tend to be as high as medical costs and other administrations in hospitals, so a CMA analysis is needed to getmoreeconomical and effective treatment cost. The study was intended to learn the minimum costs of the use of drugs from the CCB combination of ARB. The study is a descriptive observational study of retrospective nature. Studies show that of 60 patients there are 24 male patients (40%) and 36 female patients (60%). The average age of most patients between 51-60 years, with the most hospitalization is 1-5 days. The most widely used antihypertension medication is candesartan 8 mg combination of amlodipin 10 mg (42%) and candesartan 16 mg combination of amlodipin 10 mg (25%). Studies have concluded that antihypertension drugs that have a minimum costs (CMA) is candesartan 16 mg combination of amlodipin 10 mg at Rp.3.870.065.-. Where the average costs paid by patients daily for antihypertensive drugs are Rp.4.952.-, treatment costs Rp.167.819.-, doctor costs Rp. 69.619.- and room administration Rp.310.476.-. So the total daily costs incurred by hypertensive patients at RSU Imelda Pekerja Indonesia Medan amounts to Rp.552.866.-.
EVALUASI POLA TERAPI PENGOBATAN PENYAKIT-PENYAKIT PENYERTA (KOMORBID) PADA PASIEN HIV/AIDS DI RUANG RAWAT INAP RUMAH SAKIT UMUM IMELDA PEKERJA INDONESIA MEDAN Gultom, Roby
JIFI (Jurnal Ilmiah Farmasi Imelda) Vol. 6 No. 1 (2022): JIFI (Jurnal Ilmiah Farmasi Imelda)
Publisher : Universitas Imelda Medan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52943/jifarmasi.v6i1.1112

Abstract

Comorbid diseases can be found in HIV/AIDS pateients. Comorbid are comorbid diseases that are not related to the diagnosis of the main disease or the patients condition. The purpose of this study was todetermine the pattern of therapy comorbid diseases (comorbid) in HIV/AIDS patients in the inpatient room at Rumah Sakit Umum Imelda Pekerja Indonesia Medan. The sample of this study amounted to 34 people. This type of research is a descriptive observation study where the date are taken retrospectively and analyzed by descriptive statistical methods. The result showed that majority of patients in Rumah Sakit Umum Imelda Pekerja Indonesia Medan is men as many 27 people (79,4%). The most common comorbid diseases foun in HIV/AIDS patients is hyponatremiaas many 20 people (25%), hypokalemia as many 12 people (15%), and dyspepsia as many as 9 people (11,25%). The most common comorbid treatment patterns given to HIV/AIDS patients are antibiotic abd analgesic. Where the antibiotic is ceftriaxone (52.9%) and the analgesic is ketorolac (61.8%), In addition, there is the provision of diarrhea medicine using Diaform (55.9%), Stomach medicine using Antacids (52.9%), suplements using Channa (44,1%) and sedatives using Alprazolam (52.9%). In addition to treatment therapy, HIV/AIDS patients also recived blood transfusion as many as 5 people.